New award for losartan tablets with xlcare pharmaceuticals, INC. Period of performance is 9/24/2025-9/23/2026.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79725D0037
- Awardee
-
Xlcare Pharmaceuticals Inc. UEI MEAUS5WHBJJ7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Losartan Tablets Pre-Solicitation · 36E79725R0032 · Posted May 1, 2025
- Last date to order 56% complete
- IDV ceiling
- $37,933,102.70
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Xlcare Pharmaceuticals Inc. for losartan potassium tablets with a ceiling of $37,933,102.70 on September 24, 2025. Xlcare Pharmaceuticals Inc. is certified as an economically disadvantaged woman-owned small business and registered as a minority-owned, small disadvantaged business.
The contract covers supply of losartan tablets across nine configurations ranging from 25 milligrams to 100 milligrams in package sizes of 30, 90, and 1,000 tablets per bottle. Distribution occurs through the VA's Pharmaceutical Prime Vendor Program to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service.
The period of performance runs from September 24, 2025 through September 23, 2026 (base year) with four one-year option periods extending through September 23, 2027. The procurement was issued as an unrestrictive commercial item under FAR Part 12, NAICS code 325412 (Pharmaceutical Preparation Manufacturing). A modification dated April 2026 incorporated Section 5 of Executive Order 14398, Clause 52.222-90, addressing discrimination prevention into the contract.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725D0037?
36E79725D0037 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on September 24, 2025.
How much is contract 36E79725D0037 worth?
36E79725D0037's own ceiling is $37,933,103.
Who can order from contract 36E79725D0037?
36E79725D0037 is a single award indefinite delivery contract.
Was contract 36E79725D0037 competed?
The extent of competition for 36E79725D0037 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV